Moderna (MRNA) News Today

Moderna, Inc. (MRNA) shares have been volatile amid a mix of bullish trading flows, broader market sentiment shifts and negative headlines linking COVID-19 vaccines to child deaths. Key developments for investors include:

• Positive Sentiment: Signs of bullish option flow propelled Moderna’s stock higher by over 4%, reflecting increased trader optimism.Bullish flow in Moderna with shares up 4.13%
• Neutral Sentiment: September’s University of Michigan consumer sentiment reading fell, with commentary touching on Moderna’s vaccine performance alongside the Gemini IPO—more of a market-wide tone setter than a company-specific catalyst.Sept. consumer sentiment falls, Moderna & COVID report, Gemini IPO
• Negative Sentiment: Moneycontrol reports that Pfizer and Moderna shares sank after Trump administration officials were said to plan linking COVID-19 vaccines to child deaths, fueling heavy selling pressure.Pfizer, Moderna shares sink as Trump officials likely plan to link Covid vaccines to child deaths
• Negative Sentiment: MSN Politics notes shares fell as Trump officials reportedly prepare to link COVID shots to child fatalities.Moderna, Pfizer stocks fall as Trump officials reportedly link COVID shots to child deaths
• Negative Sentiment: Another MSN Money write-up explains Moderna shares traded lower on the mounting controversy around child-death linkage reports.Why Moderna (MRNA) Shares Are Trading Lower Today
• Negative Sentiment: Zacks highlights that Moderna underperformed the broader market, declining more than 7% amid the adverse vaccine linkage headlines.Moderna (MRNA) Declines More Than Market: Some Information for Investors
• Negative Sentiment: Investopedia reports Moderna plunged as vaccine makers came under pressure from the Trump administration’s reported plans to link shots with child deaths.S&P 500 Gains and Losses Today: Warner Bros. and Paramount Extend Gains; Moderna Plunges
• Negative Sentiment: The New York Post notes shares plunged 7.4% after reports that Trump officials plan to tie 25 child deaths to COVID-19 vaccines.Pfizer, Moderna shares plunge on report that Trump officials plan to link 25 child deaths to COVID vaccine
• Negative Sentiment: CNBC reports both Pfizer and Moderna stocks fell after the White House Health team’s reported plan to link child deaths to COVID shots added to investor concern.Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots
• Negative Sentiment: CNBC’s video segment discussed the alleged plan to tie child fatalities to COVID vaccines, further intensifying negative sentiment around the share price.Trump officials to link child deaths to covid shots, according to reports